These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2101438)

  • 21. Quantification of insulin secretion and in vivo insulin action in nonobese and moderately obese individuals with normal glucose tolerance.
    Reaven GM; Moore J; Greenfield M
    Diabetes; 1983 Jul; 32(7):600-4. PubMed ID: 6345239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Peripheral proinsulin level in the hyperinsulinism of obese subjects].
    Hausmann L; Schubotz R; Kaffarnik H
    Verh Dtsch Ges Inn Med; 1975; 81():1486-90. PubMed ID: 1227003
    [No Abstract]   [Full Text] [Related]  

  • 23. The G972R variant of the insulin receptor substrate-1 (IRS-1) gene is associated with insulin resistance in "uncomplicated" obese subjects evaluated by hyperinsulinemic-euglycemic clamp.
    Baroni MG; Leonetti F; Sentinelli F; Romeo S; Filippi E; Fanelli M; Ribaudo MC; Zappaterreno A; Fallarino M; Di Mario U
    J Endocrinol Invest; 2004 Sep; 27(8):754-9. PubMed ID: 15636429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Insulin, the factor implicated in the pathogenesis of obesity].
    Petrovanu R; Rusu V
    Rev Med Chir Soc Med Nat Iasi; 1985; 89(2):303-6. PubMed ID: 3911320
    [No Abstract]   [Full Text] [Related]  

  • 25. [Level of beta endorphins and insulin in blood of obese subjects. Effect of surgical treatment for obesity on higher exchange parameters].
    Twardowska-Saucha K; Pardela M; Grzeszczak W; Lacka B
    Pol Arch Med Wewn; 1993 Jul; 90(1):19-25. PubMed ID: 8234001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin receptors and insulin sensitivity in normo and hyperinsulinemic obese patients.
    Carducci Artenisio A; Ragonese F; Forte F; Saitta G; Perrone G; Lettina G; Campisi R; Consolo F
    J Endocrinol Invest; 1985 Jun; 8(3):233-9. PubMed ID: 3897356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Insulin secretion in alcoholic hepatopathy: analysis by measurement of C-peptide (author's transl)].
    Schlienger JL; Blickle F; Demangeat C; Hasselmann M; Imler M
    Nouv Presse Med; 1978 Dec; 7(44):4011-5. PubMed ID: 733568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced urinary insulin clearance in patient with abnormal insulinemia.
    Yamamoto R; Iwamoto Y; Sakura H; Yoshioka N; Hsieh SD; Matsuda A; Kuzuya T
    Diabetes; 1987 May; 36(5):602-6. PubMed ID: 3552792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum activity of beta-N-acetylglucosaminidase in obese hyperinsulinemic subjects.
    Perdichizzi G; Cucinotta D; Saitta A; Squadrito G
    Acta Diabetol Lat; 1985; 22(3):247-52. PubMed ID: 4072570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of the participation of proinsulin in hyperinsulinism in patients with obesity and glucose intolerance].
    Blicklé JF; Sapin R; Caro-Sampara F; Grasser F; Brogard JM
    Rev Med Interne; 1993; 14(10):993. PubMed ID: 8009086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-insulin antibodies interference in the Siemens Immulite chemiluminescent insulin immuno-assay.
    Iglesias P; Grande C; Cano AG; Maurí M
    Clin Chim Acta; 2013 Oct; 425():186-7. PubMed ID: 23954769
    [No Abstract]   [Full Text] [Related]  

  • 32. Insulin and the glucoregulatory alterations of RES depression.
    Hadbavny AM; Buchanan BJ; Filkins JP
    J Reticuloendothel Soc; 1978 Jul; 24(1):57-62. PubMed ID: 690996
    [No Abstract]   [Full Text] [Related]  

  • 33. [Influence of endogenous and exogenous hyperinsulinism on the excretion of insulin and blood sugar utilization. (Role of feedback in insulin secretion)].
    Páv J; Srámková J; Rames I
    Sb Lek; 1972 Jul; 74(7):250-6. PubMed ID: 5050836
    [No Abstract]   [Full Text] [Related]  

  • 34. [The functional interrelationships of blood glucose and immunoreactive insulin in the intravenous glucose tolerance test in coronary atherosclerosis patients].
    Denisova TP; Malinov IA
    Klin Lab Diagn; 1999 Jul; (7):9-11. PubMed ID: 10502919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased serum growth hormone concentrations in hypoxemic obese subjects.
    Rodger NW; Knoppert D; Sangal SP; Binns-Smith M
    Clin Invest Med; 1979; 2(4):135-40. PubMed ID: 121557
    [No Abstract]   [Full Text] [Related]  

  • 36. Portal and peripheral vein concentrations of insulin after glucose and arginine infusions in morbidly obese subjects.
    Walter RM; Gold EM; Michas CA
    Life Sci; 1980 Jan; 26(4):261-6. PubMed ID: 6986529
    [No Abstract]   [Full Text] [Related]  

  • 37. [Trends in the measurement of body heights: correlation with lipoparticle LpA1 and insulinemia in the obese].
    Lecerf JM; Fichaux MT; Bard JM
    Presse Med; 1998 Oct; 27(33):1680-1. PubMed ID: 9834782
    [No Abstract]   [Full Text] [Related]  

  • 38. Strategy to establish a cut-off point for hyperinsulinemia.
    Loria A; Arroyo P; Fernández V; Laviada H
    Rev Invest Clin; 2010; 62(3):276-8. PubMed ID: 20815134
    [No Abstract]   [Full Text] [Related]  

  • 39. Fetal hyperinsulinism in anencephaly.
    Hubinont C; Fisk NM; Nicolini U; Rodeck CH
    Am J Obstet Gynecol; 1989 Aug; 161(2):306-7. PubMed ID: 2669485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence of systematic and proportional error in a widely used glucose oxidase analyser: impact for clinical research?
    Amati F; Broskey NT; Carnero EA
    Clin Endocrinol (Oxf); 2014 May; 80(5):768-70. PubMed ID: 23800101
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.